---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-128084"
form_type: "8-K"
ticker: null
cik: "0000786947"
company_name: "ACURA PHARMACEUTICALS, INC"
filed_at: "2023-12-21T23:59:59+00:00"
generated_at: "2026-06-07T09:36:22.536911+00:00"
event_type: "debt"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Acura extends $4.67M related-party promissory note maturity to March 31, 2024

## Summary
- Original note of $4,669,279 at 5.25% interest matured Dec 31, 2023; maturity extended to March 31, 2024.
- Note held by AD Pharma, which owns ~66% of Acura common stock (excluding warrants to purchase 10M shares).
- John Schutte controls AD Pharma and directly owns ~14% of Acura.
- Overdue amounts bear default interest at 7.5%; default triggers include bankruptcy and non-payment.
- Extension provides short-term liquidity relief but highlights ongoing financial pressure.

## SEC filing metadata
- accession: 0001104659-23-128084
- form_type: 8-K
- cik: 0000786947
- company_name: ACURA PHARMACEUTICALS, INC
- filed_at: 2023-12-21T23:59:59+00:00
- event_type: debt
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 2.01, 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/786947/000110465923128084/0001104659-23-128084-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/786947/000110465923128084/tm2333501d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-128084
- JSON: https://secwatch.observer/filing/0001104659-23-128084.json
- Plain text: https://secwatch.observer/filing/0001104659-23-128084.txt

## Key facts
- Debt Financings
  ACURA PHARMACEUTICALS, INC amended loan of $4,669,279 with Abuse Deterrent Pharma, LLC at 5.25% maturing March 31, 2024.
  - Instrument: loan
  - Principal: $4,669,279
  - Counterparty: Abuse Deterrent Pharma, LLC
  - Rate: 5.25%
  - Maturity: March 31, 2024
  - Event: amendment
  source text: #1 to the November 10, 2022 Amended, Consolidated and Restated Secured Promissory Note (the “Note”). Amendment #1 has an effective date of December 7, 2023. This Note totaling $4,669,279 bears interest at 5.25% and had a maturity date of December 31, 2023, at which time all principal and interest was due. Amendment #1 changes the maturity date of the Note to March
  evidence_url: https://www.sec.gov/Archives/edgar/data/786947/000110465923128084/0001104659-23-128084-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.